Abstract
WHO-Defined Chronic Myelomonocytic Leukemia-2 (CMML-2) Patients Rapidly Progress to AML Suggesting This Entity Represents a Transitory Clinical State
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have